INTRODUCTION
Celiac disease (CD) is a gluten-sensitive enteropathy that occurs in genetically predisposed individuals after ingestion of gluten. Originally considered a malabsorption syndrome of childhood, CD is now recognized as a common condition that may be diagnosed at any age. 1 Ingestion of gluten in CD patients triggers a mucosal inflammatory response, which leads to epithelial tissue damage, villous atrophy, crypt cell hyperplasia, and increased number of intraepithelial lymphocytes (IELs). 2 The exact mechanism by which CD-associated inflammatory response is induced and sustained is not fully understood. There is evidence that gluten peptides are deamidated by the enzyme tissue transglutaminase 2, processed by antigen-presenting cells, and presented to lamina propria CD4 + T cells (T-LPLs) in the context of HLA-DQ2 / DQ8 molecules. 2 This sequence of events leads to the activation and expansion of gluten-specific T cells. 1, 2 It has also been shown that certain non-immunodominant gluten peptides derived from α -gliadin (e.g., peptides 31 -43 and 31 -49) , which are distinct from those that bind DQ2 or DQ8 and activate gluten peptide -specific CD4 + T cells, induce the production of interleukin (IL)-15 by innate immune cells, thereby leading to epithelial cell death. 3 These findings correlate with the demonstration that IL-15 is overexpressed in both the lamina propria and intestinal epithelium of patients with active CD as compared with normal controls or inactive CD patients. 4, 5 Studies examining the mechanisms by which IL-15 promotes epithelial injury have revealed that IL-15 upregulates the nonconventional HLA molecules MICA / B on enterocytes and enhances both NKG2D and DAP10 in IELs, 6 with the downstream effect of promoting IEL-mediated epithelial damage. IL-15 also controls the activation of adaptive immune responses, as substantiated by its ability to make mucosal T lymphocytes resistant to the transforming growth factor-1-mediated immune-suppression and sustain the survival of such cells. 2,7 -9 Analysis of cytokines produced by T-LPLs in the gut of CD patients has shown that CD-associated inflammation is dominated by production of interferon-(IFN-) and IL-17A, the cytokine signatures of T helper (Th) 1 and Th17 cell responses, respectively. 10, 11 In this context, we and others have recently demonstrated that in CD, gliadin-specific T cells produce high levels of IL-21, 12,13 a cytokine that is supposed to play a key role in the pathogenesis of CD. Indeed, IL-21 amplifies Th1 and Th17 cell responses, 14, 15 enhances secretion of extracellular matrixdegrading proteases by stromal cells 16 
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by epithelial cells, 17 and counterregulates the immune-suppressive activities of regulatory T cells. 18 Chromosomal 4q27 region harboring the IL-2 and IL-21 genes is associated with CD, 19 but if these genetic alterations affect IL-21 protein remains to be ascertained. Similarly, the cell source of IL-21 and the basic mechanisms that control IL-21 expression in CD mucosa are not known. In this study, we performed a single-cell analysis of IL-21-producing CD4 + T cells to ascertain which cells produce IL-21 and to investigate the factors involved in the regulation of IL-21 production in CD.
RESULTS

IL-21 is produced by both CD4 + IELs and T-LPLs in CD
To evaluate cell sources of IL-21 in CD mucosa, we performed a single-cell analysis of IL-21 production by flow cytometry using IELs and T-LPLs isolated from patients with active and inactive CD and non-CD controls. The fraction of IL-21-producing CD3 + IELs was significantly higher in active CD patients as compared with inactive CD patients and normal controls ( Figure 1a ). There was no significant difference in the percentage of such cells between inactive CD and non-CD samples ( Figure 1a ) . Similarly, the percentage of IL-21-producing T-LPLs was significantly higher in patients with active CD as compared with non-CD controls ( Figure 1c Figure 1b,d ). These data confirm precedent studies showing that IL-21 is produced by activated CD4 + but not CD4 − T cells. 20 To confirm the localization of IL-21-producing cells, duodenal sections of non-CD controls and active CD patients were stained with anti-IL-21 antibody. IL-21-positive cells were evident both in the epithelium and lamina propria of CD patients ( Figure 1e ). Western blotting of extracts of cells isolated from the epithelium and lamina propria and densitometric analysis of immunoreactive bands revealed that IL-21 expression was significantly increased in CD patients in comparison with non-CD controls ( Figure 1f,g ).
The / -positive IELs produce IL-21 in CD
A typical histological feature of CD is the increased infiltration of the epithelial layer by / -positive lymphocytes. 21 By flow cytometry we confirmed that the percentage of / -positive IELs was increased in duodenal biopsies of patients with active CD and patients with inactive CD as compared with non-CD controls ( Figure 2a ). Phenotypic analysis of / -positive IELs in the duodenal mucosa revealed that the majority of them were negative for both CD4 and CD8 with no difference between active CD and controls ( Supplementary Figure S3A 
CXCR5-positive T-LPLs are a source of IL-21 in CD
A subset of T cells, termed T follicular helper cells, provides help to B cells and represents one of the most numerous and important subsets of effector T cells in lymphoid tissues. 23 T follicular helper cells express the CXC-chemokine receptor 5 (CXCR5) and IL-21, 24 and have recently been involved in the development of immune-mediated diseases. 25, 26 We next examined whether in the human duodenum, IL-21-expressing CD4 + cells were positive for CXCR5. CXCR5 + CD4 + cells were present in lamina propria mononuclear cell (LPMC) samples of both controls and CD patients ( Figure 3a ) . Immunofluorescence of duodenal sections taken from active CD patients showed that cells positive for both CD4 and CXCR5 were mostly confined in follicular structures, although some of them were seen in the lamina propria compartments outside the follicles ( Figure 3b , right panel), thus corroborating previous data. 27 Interestingly, the percentage of IL-21-producing CXCR5 + / CD4 + T cells was higher in CD than in non-CD controls ( Figure 3c ). 
IL-15 enhances IL-21 production through an Akt-dependent mechanism
As in CD, IL-15 targets CD4 + T lymphocytes, 8 
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To determine whether IL-15 also regulates the expression of IL-21 in CXCR5 + CD4 + cells, normal jejunal CD4 + LPLs were either left unstimulated or stimulated with IL-15 and then cultured with or without phorbol 12-myristate 13-acetate (PMA) and ionomycin. After 5 h, cells were assessed by flow cytometry. Figure 5f shows that nearly 10 % of CD4 + LPLs cultured with medium alone in the absence of PMA and ionomycin were positive for CXCR5, thus indicating that expression of CXCR5 on CD4 + LPLs is not secondary to PMA / ionomycin stimulation. As expected, PMA / ionomycin stimulation doubled the fraction of CXCR5 + CD4 + cells. Treatment of cells with IL-15 increased the percentage of IL-21-expressing CXCR5 + and CXCR5 − CD4 + LPLs, without affecting the fraction of CD4 + LPLs expressing CXCR5 ( Figure 5f ).
Next, we explored mechanisms by which IL-15 regulates IL-21 production. Analysis of signaling pathways activated in T cells has previously shown that IL-15 induces strong activation of STAT5 (signal transducer and activator of transcription 5), Akt, and STAT3. 31 -33 As STAT5 does not regulate IL-21 production, 34 we initially focused our work on Akt. We monitored the phosphorylation of Akt in normal T-LPLs treated with IL-15 for different time points. By using an antibody that specifically recognizes Akt phosphorylation on serine 473 (S473) residue, we showed that IL-15 enhanced Akt activation ( Figure 6a,b ) . To inhibit Akt, cells were treated with 100 n m wortmannin (WRT), as previous studies have documented the specificity of this compound when used at this concentration. 35 WRT abrogated IL-15-induced Akt phosphorylation ( Figure 6c ) and significantly reduced IL-15-driven IL-21 and IFN-synthesis ( Figure 6d,e ) . Flow cytometric analysis revealed that WRT also reduced the fraction of IL-21 / IFN-double-positive cells ( Figure 6f ). The fact that suppression of Akt by WRT was not accompanied by abrogation of IL-15-driven IL-21 production ( Figure 6d -f ) prompted us to examine the involvement of other signaling pathways. As we previously showed that IL-21 production in T cells is positively regulated by STAT3, 36 we examined 
Activation of Akt in CD mucosa
To confirm that Akt is involved in the control of IL-21 in CD, we evaluated p-Akt in biopsies taken from active CD patients and non-CD controls. A more pronounced expression of p-Akt was seen in CD as compared with controls ( Figure 7a ). Treatment of explants, taken from active CD patients, with WRT reduced IL-21 expression ( Figure 7b ). In line with the above data, the addition of a neutralizing anti-IL-15 to cultures of CD duodenal explants reduced p-Akt and IL-21 protein and RNA expression ( Figure 7c,d ) . In a final set of experiments we assessed whether inhibition of endogenous IL-15 negatively regulated IL-21 induction in biopsies of inactive CD patients stimulated in vitro with a peptic -tryptic digest of gliadin (PT). Initially, we determined the variation in the response of individual biopsies 
DISCUSSION
CD is a disorder characterized by excessive immune response to ingested wheat gluten and related cereal proteins. 1,2 Although innate immune response seems to be sufficient to elicit epithelial damage, a considerable amount of work has been produced to indicate that gluten-reactive CD4 + T cells synthesize large 
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amounts of cytokines, which amplify the ongoing mucosal inflammation and contribute to the duodenal villous atrophy. 2, 37 In this context, we have recently shown that in active CD, mucosal T lymphocytes produce IL-21 and that this cytokine sustains the synthesis of both IFN-and IL-17A. 11, 12 Our data are consistent with the recent work by Bodd et al. , 13 showing that in CD, IL-21 and IFN-are made by glutenspecific T cells, whereas IL-17A is produced by nonglutenspecific T cells. Altogether, these observations strongly suggest a role for IL-21 in CD-associated inflammatory response.
The present study was undertaken to assess which cells produce IL-21 and how IL-21 production is regulated in CD. By performing a flow cytometry analysis at single-cell level, we showed that IL-21 production is more pronounced in patients with active CD as compared with patients with inactive CD and non-CD controls and that in CD mucosa, both CD4 + T cells and CD4 / CD8 double-positive cells express IL-21. However, it is likely that the contribution of CD4 + CD8 + cells to IL-21 production is modest as the duodenal mucosa is infiltrated with a small number of these cells. This was evident both in the epithelium and lamina propria, as confirmed by immunohistochemistry and western blotting. We also showed that / -expressing CD4 + IELs were another source of IL-21 in the human duodenum. Increased numbers of / -positive cells were observed in IEL preparations of both active and inactive CD patients, but the percentage of IL-21-expressing / -positive IELs was upregulated only in active CD. As most / -positive IELs do not seem to recognize peptides in association with major histocompatibility complex molecules, 38 it is likely that induction of IL-21 in this cell subset is driven directly by cytokines / molecules produced within the inflamed intestine following gluten ingestion rather than gluten peptides. As discussed below, IL-15 could accomplish this function.
The exact role of / -positive IELs in the pathogenesis of CD remains unclear. It has been recently suggested that CD8 + / + NKG2A + IELs exert regulatory functions in CD patients on a gluten-free diet, as these cells secrete transforming growth factor-1 and suppress the IL-15-stimulated cytotoxic activity of CD8 + IELs. 39 We were not able to purify sufficient numbers of IL-21-producing / -positive IELs to carry out functional studies. However, the fact that the majority of IL-21-expressing / -positive IELs coexpressed the inflammatory cytokine IFN-(Sarra et al. , unpublished observations) would suggest a proinflammatory role of IL-21-producing / -positive IELs. This hypothesis well fits with the demonstration that / -positive T cell-derived IL-21 enhances the production of IL-17A and IL-17F by CD4 + T cells and contributes to the pathogenesis of experimental autoimmune pathologies in mice. 40 It is thus conceivable that distinct subsets of / -positive IELs can accumulate during the various stages of CD. In the gut of active CD patients, where the excessive amount of IL-15 and IL-21 renders T cells refractory to the suppressive action of transforming growth factor-1, 9,18 effector / -positive IELs could predominate. In contrast, when gluten is withdrawn from the diet and IL-15 and IL-21 levels diminish, / -positive IELs could become regulatory under the stimulus of transforming growth factor-1 and contribute to the recovery from gluten-driven epithelial damage and maintenance of mucosal homeostasis.
The majority of IL-21-producing IELs and T-LPLs coexpressed IFN-, and to a lesser extent IL-17A or IL-22, supporting the hypothesis that in the human gut, IL-21 is preferentially made by Th1 rather than Th2 / Th17 cells. 12, 29, 41 Indeed, in active CD, nearly 40 % of IL-21-producing cells were positive for T-bet, a Th1-related transcription factor. 30 These data are in line with our previous report in which blockade of IL-21 in mucosal sample taken from active CD patients reduced T-bet expression. 12 Moreover, these findings confirm and expand on our own previously published studies showing that IL-21 is highly produced in other Th1-related gastrointestinal inflammatory disorders, such as CD and Helicobacter pylori -related gastritis. 29,41,42 
IL-21 is also produced by T follicular helper cells, a newly defined effector CD4 + T-cell subset that expresses the chemo kine receptor CXCR5, preferentially localizes to lymphoid tissue, and provides help to B cells. 27 The gut is a lymphoid tissue-rich environment and inevitably, cells from lymphoid follicles are present in LPMC preparations. CXCR5 + CD4 + cells isolated from the duodenum expressed IL-21, and the fraction of IL-21-producing CXCR5 + CD4 + LPLs was higher in active CD samples than in control samples. We do not yet know what role is played by IL-21-producing CXCR5 + CD4 + LPLs in CD, although it is conceivable that these cells could contribute to the enhanced production of auto-antibodies and promote CD8 + T cell-driven tissue damage in line with data generated in other systems. 26, 43 Data of the present work show that IL-15 positively regulates IL-21 expression in T-LPLs, and that IL-15-mediated IL-21 induction is enhanced by T cell receptor signaling. The positive effect of IL-15 on IL-21 synthesis was seen in both CXCR5-positive and CXCR5-negative T cells. Analysis of mechanisms by which IL-15 controls IL-21 production revealed that IL-15 activates both Akt and STAT3 in intestinal CD4 + LPLs and that simultaneous inhibition of Akt and STAT3 suppresses almost completely IL-15-induced IL-21 synthesis. In contrast, the antiapoptotic effect of IL-15 on intestinal CD4 + lymphocytes does not seem to rely on Akt, because preincubation of T-LPLs with WRT did not revert the prosurvival effect of IL-15. These later findings are consistent with data published by Malamut et al. , 44 showing that the pro-survival effect of IL-15 on IELs is not inhabitable by WRT. Duodenal biopsies of active CD patients displayed high levels of active Akt, and treatment of such samples with WRT reduced IL-21 production, thus confirming the role of Akt in driving IL-21 synthesis. Consistent with the above data, blockade of IL-15 in ex vivo cultures of CD biopsies reduced both Akt phosphorylation and IL-21 production. In line with our data is the demonstration that Akt drives inflammatory signals in other immune-mediated diseases such as systemic lupus erytemathosus, rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. 45 -49 Studies are now in progress to dissect the basic mechanisms by which Akt regulates IL-21 production in CD. Further work would also be necessary to ascertain whether IL-21 positively regulates IL-15 production, thereby facilitating a positive feedback loop that contributes to amplify the ongoing mucosal inflammation.
In conclusion, our study provides a detailed analysis of IL-21-producing T cells in CD mucosa and shows that IL-15 positively regulates IL-21 production. As IL-21 enhances IL-17A and IFN-synthesis in CD, 11, 12 our findings contribute to delineate a scenario in which several cytokines produced by different T-cell populations help amplify the gluten-driven inflammation.
METHODS
Mucosal samples . Duodenal biopsies were taken from 38 patients with active CD during upper gastrointestinal endoscopy. The histopathological diagnosis of CD was based on typical mucosal lesions with crypt cell hyperplasia and villous atrophy. All active CD patients were positive for anti-endomysial and anti-transglutaminase antibodies at the time of diagnosis. Biopsies were also obtained from 15 inactive CD patients who adhered to a strict gluten-free diet and were in clinical and histological remission and negative for anti-endomysial and anti-transglutaminase antibodies. Non-CD controls ( N = 28) were under investigation for gastrointestinal symptoms, but had normal histology and no increase in inflammatory cells. Normal jejunal surgical specimens were available from eight patients who underwent gastro-jejunal bypass for obesity. Informed consent was obtained from all patients and controls and the study protocol was approved by the local ethics committee.
Cell isolation and culture . All reagents were from Sigma-Aldrich (Milan, Italy) unless specified. LPMCs and IELs were isolated as previously described 11 and resuspended (1 × 10 6 per ml) in RPMI-1640 supplemented with 10 % fetal bovine serum, penicillin (100 U ml − 1 ), streptomycin (100 g ml − 1 ), and gentamycin (50 g ml − 1 ; complete medium; Lonza, Milan, Italy).
LPMCs were also isolated from jejunum surgical specimens of eight normal controls. LPMCs were used to purify CD4 + T-LPLs using a CD4 + cell isolation kit (Miltenyi Biotec, Bologna, Italy) according to the manufacturer ' s instruction. The resulting cell preparations ( > 95 % CD4 + ) contained > 85 % of viable cells as assessed by flow cytometry.
IELs (2 × 10 5 ) and T-LPLs (2 × 10 5 ) were cultured in complete medium with PMA (40 ng ml − 1 ), ionomycin (1 mg ml − 1 ), and monensin (2 m , eBioscience, San Diego, CA) for 5 h, and then assessed by flow cyto metry. Additionally, T-LPLs (1 × 10 6 cells per ml) were cultured in complete medium with recombinant human IL-15 (50 ng ml − In all experiments, appropriate isotype control IgG (Becton Dickinson) was used. All antibodies were used in a 1:50 final dilution. For intracellular staining, cells were fixed and permeabilized using IC Fixation buffer and the permeabilization buffer (both from eBioscience) according to the manufacturer ' s instruction.
Immunohistochemistry and immunofluorescence . Tissue sections from three non-CD controls and three patients with active CD were cut, deparaffinized, dehydrated through xylene and ethanol, and incubated with a rabbit anti-human IL-21 antibody (Millipore, Milan, Italy) for 1 h at room temperature. Immunoreactive cells were visualized using MACH4 Universal HRP-Polymer kit with DAB (Biocare Medical, CA), according to the manufacturer ' s instructions, and lightly counterstained with hematoxylin. Isotype control sections were prepared under identical immunohistochemical conditions, as described above, replacing the primary antibody with a purified, normal rabbit IgG control antibody (Dako, Glostrup, Denmark).
Frozen sections of four active CD patients were also stained with antihuman CD4 (Santa Cruz Biotechnology, DBA, Milan, Italy) and CXCR5 (1:100 final dilution, R & D Systems) followed by incubation with a highly sensitive biotinylated secondary antibody (Dako) and Tyramide signal amplification kit (Perkin Elmer, Waltham, MA) or with cy3-conjugated secondary antibody (1:200 final dilution, Jackson Immunoresearch, Starfish, Milan, Italy).
